Skip to main
NGVT
NGVT logo

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity (NGVT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Ingevity Corp is poised for a positive outlook as management's strategic execution, including a recent asset sale, aims to enhance the company's portfolio by minimizing operational complexities. This move is expected to lead to reduced earnings volatility and an improved margin profile, which are critical factors for long-term financial stability and growth. Additionally, the company's strong revenue generation from its Performance Chemicals segment underscores its robust market position within the specialty chemicals industry.

Bears say

Ingevity Corp faces significant challenges that cast a negative outlook on its stock, primarily linked to the potential decline in global auto production, which could adversely affect the company's earnings and valuation multiple. Additionally, the company's reliance on the Performance Materials segment for automotive carbon products raises concerns about its ability to successfully transition towards AFA, which could further exacerbate revenue volatility. Furthermore, the company may encounter increased risks from various factors, including a patent cliff, tariffs affecting its Performance Materials sector, and competitive pressures that could impact profit margins.

Ingevity (NGVT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ingevity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ingevity (NGVT) Forecast

Analysts have given Ingevity (NGVT) a Hold based on their latest research and market trends.

According to 2 analysts, Ingevity (NGVT) has a Hold consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ingevity (NGVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.